ACE and coronary artery disorder: Thus far, multiple clinical trials and cohort studies have demonstrated that ACE inhibitors are beneficial to patients with hypertension, diabetes, renal disease, heart dysfunction, also to patients with coronary artery disease (CAD), and valve diseases1–8.